CPAP reduces risk of death in people with COPD and sleep apnea
More time on CPAP was associated with reduced mortality after controlling for common risk factorsDARIEN, IL – A new study suggests that continuous positive airway pressure (CPAP) therapy reduces the mortality rate in people who have both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), which the authors refer to as “the overlap syndrome.” “This study adds to the growing body of literature regarding the combined impact of OSA in patients with COPD,” said lead author and principal investigator Michael L. Stanchina, MD, clinical assistant professor of medicine
